跳至主要内容
临床试验/NL-OMON43286
NL-OMON43286撤回不适用

Performance of bioresorbarble scaffold in primary percutaneous intervention of ST elevation myocardial infarct - BVS in STEMI

Academisch Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) History of chest pain < 12 hrs
  • 2) ST elevation of * 2 mm in *2 contiguous precordial leads (V1-V6), and/or * 1 mm in * 2 contiguous standard leads (I, II, III, aVf, aVr,aVl).
  • 3) Clinical decision to treat with primary PCI
  • 4) > 18 years
  • 5) Oral informed consent

排除标准

  • 1) Contraindications to long term DAPT
  • 2) Known kidney failure with GFR < 45
  • 3) Cardiac arrest or severe cardiogenic shock (Persistent BP <90 mmHg, despite adequate treatment)
  • 4) Other severe illness with life expectancy of less than 12 months (eg. malignancy, severe malnutrition, degenerative disease);Procedural contra-indications:
  • 1) Heavy calcification, tortuous vessel or large side branch (> 2,5 mm) at culprit lesion.
  • 2) TIMI 0-1 flow after aspiration
  • 3) Unable to advance thrombus aspiration catheter

研究者

相似试验